TY - JOUR AU - Apostolopoulos, Vasso AU - Pietersz, Geoffrey A. AU - Tsibanis, Anastasios AU - Tsikkinis, Annivas AU - Drakaki, Heleni AU - Loveland, Bruce E. AU - Piddlesden, Sara J. AU - Plebanski, Magdalena AU - Pouniotis, Dodie S. AU - Alexis, Michael N. AU - McKenzie, Ian F. AU - Vassilaros, Stamatis PY - 2006 DA - 2006/06/15 TI - Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] JO - Breast Cancer Research SP - R27 VL - 8 IS - 3 AB - Mucin 1 (MUC1) is a high molecular weight glycoprotein overexpressed on adenocarcinoma cells and is a target for immunotherapy protocols. To date, clinical trials against MUC1 have included advanced cancer patients. Herein, we report a trial using early stage breast cancer patients and injection of oxidized mannan-MUC1. SN - 1465-542X UR - https://doi.org/10.1186/bcr1505 DO - 10.1186/bcr1505 ID - Apostolopoulos2006 ER -